Life-threatening metastasis was suppressed by trastuzumab containing regimen in a patient with Her2-negative breast cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-06-23

AUTHORS

Kazunori Takahashi, Hiroshi Nakagomi, Masayuki Inoue, Yuko Nakayama, Kazushige Furuya, Masahiro Maruyama, Atsushi Takano, Hidemitsu Sugai, Masao Hada, Yoshiaki Miyasaka, Kenji Amemiya, Toshio Oyama

ABSTRACT

A 49-year-old female was referred to our hospital with left breast cancer and subsequently underwent mastectomy and axillary dissection. The pathological findings showed invasive breast cancer with lymph node metastasis (2/22), nuclear grade 3, ER (6+) PgR (2+) for the Allred score, and Her2 (2+) in an immunohistochemistry. We determined the subtype of Her2-negative breast cancer according to the fluorescent in situ hybridization results, as follows: Her2/CEP17 ratio 1.1 < 2.0. The patient received the EC regimen followed by docetaxel, and toremifene was subsequently administered. One year after the operation, the CA15-3 level was elevated at 50 ng/ml, and CT revealed liver metastases. Disease progression was not suppressed by paclitaxel containing regimen and eribulin. Then, we subsequently sought to determine whether the metastatic lesion showed the Her2 expression. Although the Her2 expression in the axillary lymph node metastases showed heterogeneous staining, the results were judged as Her2 (1+) according to the ASCO/CAP guidelines. We decided to administer trastuzumab and docetaxel due to the patient’s life-threatening status, after which the CA15-3 level decreased and the symptom of fatigue improved. A total of 9 cycles of trastuzumab and docetaxel were administered, followed by maintenance trastuzumab continued to the present time. Physicians should be aware of the statement in the ASCO/CAP guidelines that the clinical decision to ultimately consider Her2-targeted therapy should be individualized according to the patient’s status. More... »

PAGES

61-65

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13691-015-0228-4

DOI

http://dx.doi.org/10.1007/s13691-015-0228-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1045321767

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/31149426


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takahashi", 
        "givenName": "Kazunori", 
        "id": "sg:person.0630613007.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630613007.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakagomi", 
        "givenName": "Hiroshi", 
        "id": "sg:person.01152576336.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152576336.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Inoue", 
        "givenName": "Masayuki", 
        "id": "sg:person.01354217107.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354217107.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakayama", 
        "givenName": "Yuko", 
        "id": "sg:person.01301235631.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301235631.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Furuya", 
        "givenName": "Kazushige", 
        "id": "sg:person.01265174206.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265174206.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maruyama", 
        "givenName": "Masahiro", 
        "id": "sg:person.01327356207.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327356207.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takano", 
        "givenName": "Atsushi", 
        "id": "sg:person.0773611633.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0773611633.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sugai", 
        "givenName": "Hidemitsu", 
        "id": "sg:person.01015045552.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01015045552.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hada", 
        "givenName": "Masao", 
        "id": "sg:person.01224023431.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224023431.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miyasaka", 
        "givenName": "Yoshiaki", 
        "id": "sg:person.0603752107.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603752107.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Pathology, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Amemiya", 
        "givenName": "Kenji", 
        "id": "sg:person.01271466715.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271466715.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.417333.1", 
          "name": [
            "Department of Pathology, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Oyama", 
        "givenName": "Toshio", 
        "id": "sg:person.011405362052.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011405362052.18"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/modpathol.2008.34", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007014320", 
          "https://doi.org/10.1038/modpathol.2008.34"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12032-013-0798-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001424934", 
          "https://doi.org/10.1007/s12032-013-0798-y"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-06-23", 
    "datePublishedReg": "2015-06-23", 
    "description": "Abstract\nA 49-year-old female was referred to our hospital with left breast cancer and subsequently underwent mastectomy and axillary dissection. The pathological findings showed invasive breast cancer with lymph node metastasis (2/22), nuclear grade 3, ER (6+) PgR (2+) for the Allred score, and Her2 (2+) in an immunohistochemistry. We determined the subtype of Her2-negative breast cancer according to the fluorescent in situ hybridization results, as follows: Her2/CEP17 ratio 1.1\u00a0<\u00a02.0. The patient received the EC regimen followed by docetaxel, and toremifene was subsequently administered. One year after the operation, the CA15-3 level was elevated at 50\u00a0ng/ml, and CT revealed liver metastases. Disease progression was not suppressed by paclitaxel containing regimen and eribulin. Then, we subsequently sought to determine whether the metastatic lesion showed the Her2 expression. Although the Her2 expression in the axillary lymph node metastases showed heterogeneous staining, the results were judged as Her2 (1+) according to the ASCO/CAP guidelines. We decided to administer trastuzumab and docetaxel due to the patient\u2019s life-threatening status, after which the CA15-3 level decreased and the symptom of fatigue improved. A total of 9 cycles of trastuzumab and docetaxel were administered, followed by maintenance trastuzumab continued to the present time. Physicians should be aware of the statement in the ASCO/CAP guidelines that the clinical decision to ultimately consider Her2-targeted therapy should be individualized according to the patient\u2019s status.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s13691-015-0228-4", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1136680", 
        "issn": [
          "2192-3183", 
          "2192-3183"
        ], 
        "name": "International Cancer Conference Journal", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "5"
      }
    ], 
    "keywords": [
      "HER2-negative breast cancer", 
      "ASCO/CAP guidelines", 
      "life-threatening status", 
      "CA15-3 levels", 
      "lymph node metastasis", 
      "breast cancer", 
      "node metastasis", 
      "CAP guidelines", 
      "HER2 expression", 
      "axillary lymph node metastasis", 
      "nuclear grade 3", 
      "cycles of trastuzumab", 
      "left breast cancer", 
      "invasive breast cancer", 
      "symptoms of fatigue", 
      "life-threatening metastases", 
      "HER2/CEP17", 
      "ER-PgR", 
      "EC regimen", 
      "maintenance trastuzumab", 
      "underwent mastectomy", 
      "axillary dissection", 
      "liver metastases", 
      "pathological findings", 
      "metastatic lesions", 
      "disease progression", 
      "Allred score", 
      "grade 3", 
      "patient status", 
      "trastuzumab", 
      "clinical decision", 
      "metastasis", 
      "regimen", 
      "cancer", 
      "heterogeneous staining", 
      "docetaxel", 
      "HER2", 
      "patients", 
      "situ hybridization results", 
      "status", 
      "guidelines", 
      "mastectomy", 
      "toremifene", 
      "eribulin", 
      "hospital", 
      "therapy", 
      "immunohistochemistry", 
      "lesions", 
      "expression", 
      "symptoms", 
      "subtypes", 
      "physicians", 
      "paclitaxel", 
      "dissection", 
      "progression", 
      "CT", 
      "staining", 
      "CEP17", 
      "levels", 
      "PgR", 
      "scores", 
      "total", 
      "females", 
      "hybridization results", 
      "years", 
      "fatigue", 
      "findings", 
      "present time", 
      "results", 
      "time", 
      "fluorescent", 
      "cycle", 
      "statements", 
      "decisions", 
      "operation"
    ], 
    "name": "Life-threatening metastasis was suppressed by trastuzumab containing regimen in a patient with Her2-negative breast cancer", 
    "pagination": "61-65", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1045321767"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13691-015-0228-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "31149426"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13691-015-0228-4", 
      "https://app.dimensions.ai/details/publication/pub.1045321767"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_670.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s13691-015-0228-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13691-015-0228-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13691-015-0228-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13691-015-0228-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13691-015-0228-4'


 

This table displays all metadata directly associated to this object as RDF triples.

223 TRIPLES      22 PREDICATES      103 URIs      93 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13691-015-0228-4 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author Ndf9c973dbcd344f58880572e9dab2be0
4 schema:citation sg:pub.10.1007/s12032-013-0798-y
5 sg:pub.10.1038/modpathol.2008.34
6 schema:datePublished 2015-06-23
7 schema:datePublishedReg 2015-06-23
8 schema:description Abstract A 49-year-old female was referred to our hospital with left breast cancer and subsequently underwent mastectomy and axillary dissection. The pathological findings showed invasive breast cancer with lymph node metastasis (2/22), nuclear grade 3, ER (6+) PgR (2+) for the Allred score, and Her2 (2+) in an immunohistochemistry. We determined the subtype of Her2-negative breast cancer according to the fluorescent in situ hybridization results, as follows: Her2/CEP17 ratio 1.1 < 2.0. The patient received the EC regimen followed by docetaxel, and toremifene was subsequently administered. One year after the operation, the CA15-3 level was elevated at 50 ng/ml, and CT revealed liver metastases. Disease progression was not suppressed by paclitaxel containing regimen and eribulin. Then, we subsequently sought to determine whether the metastatic lesion showed the Her2 expression. Although the Her2 expression in the axillary lymph node metastases showed heterogeneous staining, the results were judged as Her2 (1+) according to the ASCO/CAP guidelines. We decided to administer trastuzumab and docetaxel due to the patient’s life-threatening status, after which the CA15-3 level decreased and the symptom of fatigue improved. A total of 9 cycles of trastuzumab and docetaxel were administered, followed by maintenance trastuzumab continued to the present time. Physicians should be aware of the statement in the ASCO/CAP guidelines that the clinical decision to ultimately consider Her2-targeted therapy should be individualized according to the patient’s status.
9 schema:genre article
10 schema:inLanguage en
11 schema:isAccessibleForFree true
12 schema:isPartOf N7886b6e951e34e219cd022b1b06b1b71
13 Nb6ac8f9d43e34653a927194c13f3268c
14 sg:journal.1136680
15 schema:keywords ASCO/CAP guidelines
16 Allred score
17 CA15-3 levels
18 CAP guidelines
19 CEP17
20 CT
21 EC regimen
22 ER-PgR
23 HER2
24 HER2 expression
25 HER2-negative breast cancer
26 HER2/CEP17
27 PgR
28 axillary dissection
29 axillary lymph node metastasis
30 breast cancer
31 cancer
32 clinical decision
33 cycle
34 cycles of trastuzumab
35 decisions
36 disease progression
37 dissection
38 docetaxel
39 eribulin
40 expression
41 fatigue
42 females
43 findings
44 fluorescent
45 grade 3
46 guidelines
47 heterogeneous staining
48 hospital
49 hybridization results
50 immunohistochemistry
51 invasive breast cancer
52 left breast cancer
53 lesions
54 levels
55 life-threatening metastases
56 life-threatening status
57 liver metastases
58 lymph node metastasis
59 maintenance trastuzumab
60 mastectomy
61 metastasis
62 metastatic lesions
63 node metastasis
64 nuclear grade 3
65 operation
66 paclitaxel
67 pathological findings
68 patient status
69 patients
70 physicians
71 present time
72 progression
73 regimen
74 results
75 scores
76 situ hybridization results
77 staining
78 statements
79 status
80 subtypes
81 symptoms
82 symptoms of fatigue
83 therapy
84 time
85 toremifene
86 total
87 trastuzumab
88 underwent mastectomy
89 years
90 schema:name Life-threatening metastasis was suppressed by trastuzumab containing regimen in a patient with Her2-negative breast cancer
91 schema:pagination 61-65
92 schema:productId N16d8239a6dd74e37bda1f62e22289c7d
93 N5c87a67d33e643c8af1ca4953bd7333a
94 N839802f1e06446c3aa402cc918f9c6d1
95 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045321767
96 https://doi.org/10.1007/s13691-015-0228-4
97 schema:sdDatePublished 2022-05-20T07:31
98 schema:sdLicense https://scigraph.springernature.com/explorer/license/
99 schema:sdPublisher N2790e8dff974420cb08671a63e202549
100 schema:url https://doi.org/10.1007/s13691-015-0228-4
101 sgo:license sg:explorer/license/
102 sgo:sdDataset articles
103 rdf:type schema:ScholarlyArticle
104 N16d8239a6dd74e37bda1f62e22289c7d schema:name pubmed_id
105 schema:value 31149426
106 rdf:type schema:PropertyValue
107 N21be9adbf7e141bdafd24d9e2ac057e8 rdf:first sg:person.01327356207.01
108 rdf:rest Na48f6a7af43048cd8a34e11a226fb5b1
109 N2790e8dff974420cb08671a63e202549 schema:name Springer Nature - SN SciGraph project
110 rdf:type schema:Organization
111 N2855aed8187441d4aa89c4b6d9730df7 rdf:first sg:person.01015045552.72
112 rdf:rest Nc2c98336fe4a4b9c96ce57035cd04d72
113 N341a22c2b17645499ade1a2cff16523f rdf:first sg:person.011405362052.18
114 rdf:rest rdf:nil
115 N3c1f303b13594547815285cab3f3bfb1 rdf:first sg:person.01271466715.07
116 rdf:rest N341a22c2b17645499ade1a2cff16523f
117 N5c87a67d33e643c8af1ca4953bd7333a schema:name doi
118 schema:value 10.1007/s13691-015-0228-4
119 rdf:type schema:PropertyValue
120 N66afac3ff187447282733169b00d7646 rdf:first sg:person.01152576336.53
121 rdf:rest Nc699d4c638fd45f2b3da9f0b633f6638
122 N6ddab7b512384c60a8081788f019e94f rdf:first sg:person.01265174206.02
123 rdf:rest N21be9adbf7e141bdafd24d9e2ac057e8
124 N7886b6e951e34e219cd022b1b06b1b71 schema:issueNumber 1
125 rdf:type schema:PublicationIssue
126 N839802f1e06446c3aa402cc918f9c6d1 schema:name dimensions_id
127 schema:value pub.1045321767
128 rdf:type schema:PropertyValue
129 N97324b639259471a89e03c1a4a17e6ee rdf:first sg:person.0603752107.03
130 rdf:rest N3c1f303b13594547815285cab3f3bfb1
131 N9c7f72aab59e4cb18a69cc3d8ab61cee rdf:first sg:person.01301235631.15
132 rdf:rest N6ddab7b512384c60a8081788f019e94f
133 Na48f6a7af43048cd8a34e11a226fb5b1 rdf:first sg:person.0773611633.23
134 rdf:rest N2855aed8187441d4aa89c4b6d9730df7
135 Nb6ac8f9d43e34653a927194c13f3268c schema:volumeNumber 5
136 rdf:type schema:PublicationVolume
137 Nc2c98336fe4a4b9c96ce57035cd04d72 rdf:first sg:person.01224023431.12
138 rdf:rest N97324b639259471a89e03c1a4a17e6ee
139 Nc699d4c638fd45f2b3da9f0b633f6638 rdf:first sg:person.01354217107.78
140 rdf:rest N9c7f72aab59e4cb18a69cc3d8ab61cee
141 Ndf9c973dbcd344f58880572e9dab2be0 rdf:first sg:person.0630613007.44
142 rdf:rest N66afac3ff187447282733169b00d7646
143 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
144 schema:name Medical and Health Sciences
145 rdf:type schema:DefinedTerm
146 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
147 schema:name Oncology and Carcinogenesis
148 rdf:type schema:DefinedTerm
149 sg:journal.1136680 schema:issn 2192-3183
150 schema:name International Cancer Conference Journal
151 schema:publisher Springer Nature
152 rdf:type schema:Periodical
153 sg:person.01015045552.72 schema:affiliation grid-institutes:grid.417333.1
154 schema:familyName Sugai
155 schema:givenName Hidemitsu
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01015045552.72
157 rdf:type schema:Person
158 sg:person.011405362052.18 schema:affiliation grid-institutes:grid.417333.1
159 schema:familyName Oyama
160 schema:givenName Toshio
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011405362052.18
162 rdf:type schema:Person
163 sg:person.01152576336.53 schema:affiliation grid-institutes:grid.417333.1
164 schema:familyName Nakagomi
165 schema:givenName Hiroshi
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152576336.53
167 rdf:type schema:Person
168 sg:person.01224023431.12 schema:affiliation grid-institutes:grid.417333.1
169 schema:familyName Hada
170 schema:givenName Masao
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224023431.12
172 rdf:type schema:Person
173 sg:person.01265174206.02 schema:affiliation grid-institutes:grid.417333.1
174 schema:familyName Furuya
175 schema:givenName Kazushige
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265174206.02
177 rdf:type schema:Person
178 sg:person.01271466715.07 schema:affiliation grid-institutes:grid.417333.1
179 schema:familyName Amemiya
180 schema:givenName Kenji
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271466715.07
182 rdf:type schema:Person
183 sg:person.01301235631.15 schema:affiliation grid-institutes:grid.417333.1
184 schema:familyName Nakayama
185 schema:givenName Yuko
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301235631.15
187 rdf:type schema:Person
188 sg:person.01327356207.01 schema:affiliation grid-institutes:grid.417333.1
189 schema:familyName Maruyama
190 schema:givenName Masahiro
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327356207.01
192 rdf:type schema:Person
193 sg:person.01354217107.78 schema:affiliation grid-institutes:grid.417333.1
194 schema:familyName Inoue
195 schema:givenName Masayuki
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354217107.78
197 rdf:type schema:Person
198 sg:person.0603752107.03 schema:affiliation grid-institutes:grid.417333.1
199 schema:familyName Miyasaka
200 schema:givenName Yoshiaki
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603752107.03
202 rdf:type schema:Person
203 sg:person.0630613007.44 schema:affiliation grid-institutes:grid.417333.1
204 schema:familyName Takahashi
205 schema:givenName Kazunori
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630613007.44
207 rdf:type schema:Person
208 sg:person.0773611633.23 schema:affiliation grid-institutes:grid.417333.1
209 schema:familyName Takano
210 schema:givenName Atsushi
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0773611633.23
212 rdf:type schema:Person
213 sg:pub.10.1007/s12032-013-0798-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1001424934
214 https://doi.org/10.1007/s12032-013-0798-y
215 rdf:type schema:CreativeWork
216 sg:pub.10.1038/modpathol.2008.34 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007014320
217 https://doi.org/10.1038/modpathol.2008.34
218 rdf:type schema:CreativeWork
219 grid-institutes:grid.417333.1 schema:alternateName Department of Pathology, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan
220 Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan
221 schema:name Department of Pathology, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan
222 Department of Surgery, Yamanashi Prefectural Central Hospital, Fujimi 1-1-1, Kofu, Yamanashi, Japan
223 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...